SCHEMBL602247

SCHEMBL602247

O=C(N=NC(=O)OCc1ccccc1)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
TDP1 Q9NUW8 2/20 0.59
MAPK1 P28482 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
SLC6A2 P23975 1/20 0.59
SLC6A3 Q01959 1/20 0.59
KMT2A Q03164 1/20 0.59
LMNA P02545 3/20 0.53
HCAR2 Q8TDS4 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.49
CA12 O43570 2/20 0.48
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
CA9 Q16790 2/20 0.48
TSHR P16473 2/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL602246 1.00 ALDH1A1 (0.61) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL6673422 0.94 ALDH1A1 (0.55) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843558 0.91 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843754 0.91 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843753 0.91 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL12494277 0.91 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843557 0.91 ALDH1A1 (0.56) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843018 0.89 ALDH1A1 (0.50) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL15843017 0.89 ALDH1A1 (0.50) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL12377043 0.89 ALDH1A1 (0.50) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 962 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079717-A Efficient oxygen deleting reagent and application thereof in carbon resource molecular skeleton deoxidizing reconstruction 2026-05-26 CN claimed
CN-122036738-A Chiral indolone spirochroman compound, and synthetic method and application thereof 成都大学 2026-05-15 CN claimed
US-12497374-B2 Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom CHIROGATE INTERNATIONAL INC. (TW) 2025-12-16 US claimed
EP-4273131-B1 PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF CARBAPROSTACYCLIN ANALOGUES CHIROGATE INT INC (TW) 2025-07-02 EP claimed
CN-120004810-A Trifluoroethyl thioether compound containing pyrimidyl amine 湖南化工研究院有限公司 2025-05-16 CN claimed
CN-119993751-A Electrode material, preparation method thereof and capacitor 湖北亿纬动力有限公司 2025-05-13 CN claimed
CN-119936221-A Genotoxic impurity detection method, minocycline hydrochloride capsule and preparation method 海口市制药厂有限公司 2025-05-06 CN claimed
CN-119852511-A Electrolyte, preparation method of electrolyte and lithium ion battery 惠州亿纬锂能股份有限公司 2025-04-18 CN claimed
WO-2025067218-A1 PREPARATION METHOD FOR DEUTERATED PROPARGYLAMINE HYDROCHLORIDE, INTERMEDIATE THEREOF, AND USE 浙江华海药业股份有限公司 2025-04-03 WO claimed
WO-2025070241-A1 COMPOUND OR SALT THEREOF, AND METHOD FOR PRODUCING THE SAME 藤本化学製品株式会社 2025-04-03 WO claimed
US-20070166809-A1 Processes for the preparations of optically active cyclopentenones and cyclopentenones prepared therefrom CHIROGATE INTERNATIONAL INC. 2007-07-19 US claimed
EP-0981959-B1 Stable 3-isothiazolone compositions ROHM & HAAS (US) 2002-10-30 EP claimed
US-6153633-A Stable 3-isothiazolone compositions ROHM AND HAAS COMPANY (US) 2000-11-28 US claimed
EP-0981959-A1 Stable 3-isothiazolone compositions ROHM AND HAAS COMPANY (US) 2000-03-01 EP claimed
EP-0545591-B1 Heat curable organopolysiloxane compositions and preformed latent platinum catalysts GEN ELECTRIC (US) 1997-02-05 EP claimed
US-5432140-A Complex of platinum and organic nitrogen compound GENERAL ELECTRIC COMPANY (US) 1995-07-11 US claimed
US-5331075-A Blend of polysiloxanes, one containing vinyl group and the other a silicon hydride group GENERAL ELECTRIC COMPANY (US) 1994-07-19 US claimed
EP-0545591-A1 Heat curable organopolysiloxane compositions and preformed latent platinum catalysts GENERAL ELECTRIC COMPANY (US) 1993-06-09 EP claimed
US-4865648-A ELECTRON DONOR DYE; ESTER; PHENOL, CARBOXY ACID, PHOSPHATE ESTER, TRIAZOLE KITO TSUTOMU (JP) 1989-09-12 US claimed
US-4720301-A Reversible heat sensitive recording composition PILOT INK CO., LTD. (JP) 1988-01-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12497374-B2 Processes and intermediates for the preparations of benzoprostacyclin analogues and benzoprostacyclin analogues prepared therefrom PTGIS, PTGER1, PTGIR ALDH1A1 1266/4885TDP1 4310/4885MAPK1 244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.